PamelaP.(Pierce)PalmerMDPhD
Anesthesiology • Redwood City, CAPain Medicine, Pediatric Pain Medicine
Chief Medical Officer and Co-Founder, AcelRx Pharmaceuticals
Dr. Palmer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
351 Galveston Drive
Redwood City, CA 94063Phone+1 650-216-3504Fax+1 650-216-6500- Is this information wrong?
Education & Training
University of California (San Francisco)Fellowship, Pain Medicine, 1996 - 1997
Santa Clara Valley Medical CenterInternship, Transitional Year, 1992 - 1993
Stanford University School of MedicineClass of 1992
Certifications & Licensure
CA State Medical License 1994 - 2026- American Board of Anesthesiology Anesthesiology
Publications & Presentations
PubMed
- 6 citationsPooled Dosing and Efficacy Analysis of the Sufentanil Sublingual Tablet 30 mcg Across Demographic Subgroups for the Management of Moderate-to-Severe Acute Pain.Jacob L Hutchins, David Leiman, Zubaid Rafique, Karen P. DiDonato, Pamela P. Palmer> ;Journal of Perianesthesia Nursing. 2020 Feb 1
- 21 citationsSufentanil sublingual tablet 30 mcg for moderate-to-severe acute pain in the EDJames R. Miner, Zubaid Rafique, Harold S. Minkowitz, Karen P. DiDonato, Pamela Pierce Palmer> ;The American Journal of Emergency Medicine. 2018 Jun 1
- 24 citationsSufentanil Sublingual Tablet 30 mcg for the Management of Pain Following Abdominal Surgery: A Randomized, Placebo-Controlled, Phase-3 StudyHarold S. Minkowitz, David A. Leiman, Timothy I. Melson, Neil Singla, Karen P. DiDonato, Pamela Pierce Palmer> ;Pain Practice. 2017 Sep 1
- Join now to see all
Press Mentions
AcelRx Announces an Investigator-Initiated Study of DSUVIA® in Patients Taking Buprenorphine Who Require a Surgical ProcedureApril 8th, 2021- AcelRx Pharmaceuticals : Announces an Investigator-Initiated Study of DSUVIA® in Cardiac Surgery Enhanced Recovery RegimenJanuary 19th, 2021
- AcelRx Pharmaceuticals : Announces an Investigator-Initiated Study of DSUVIA® in Orthopedic Patients in the Perioperative SettingAugust 24th, 2020
- Join now to see all
Grant Support
- Transcription Regulation &Interaction Of ORL1 And GAIPNational Institute Of Neurological Disorders And Stroke2004–2007
- Nociceptin &Orl1 Receptor In Synovial Inflammation/PainNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1999–2003
- Subcutaneous Infusion Of Sufentanil Citrate For PainNational Center For Research Resources2000–2002
- 5-HT Receptors--Peripheral Pain And InflammationNational Institute Of Neurological Disorders And Stroke1997–2001
- 5HT Receptors--Peripheral Pain And InflammationNational Institute Of Neurological Disorders And Stroke1999
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
